Stericycle, Inc. (NASDAQ:SRCL) Receives Average Rating of “Hold” from Analysts

Stericycle, Inc. (NASDAQ:SRCL) has been given a consensus recommendation of “Hold” by the six analysts that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $74.00.

SRCL has been the topic of several research analyst reports. Royal Bank of Canada reiterated a “sector perform” rating and issued a $62.00 price objective (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. StockNews.com started coverage on Stericycle in a research note on Tuesday, September 17th. They set a “hold” rating for the company. Keefe, Bruyette & Woods boosted their target price on Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. Finally, Truist Financial boosted their target price on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research note on Tuesday, June 4th.

Stericycle Price Performance

SRCL stock opened at $61.68 on Monday. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $5.73 billion, a PE ratio of -280.36, a P/E/G ratio of 3.37 and a beta of 1.11. Stericycle has a 12-month low of $37.78 and a 12-month high of $61.77. The business’s fifty day moving average price is $59.33 and its 200 day moving average price is $54.86.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. On average, sell-side analysts anticipate that Stericycle will post 2.29 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in SRCL. Pentwater Capital Management LP acquired a new position in shares of Stericycle during the 2nd quarter worth about $83,010,000. Magnetar Financial LLC acquired a new position in shares of Stericycle during the 2nd quarter worth about $81,596,000. Millennium Management LLC boosted its position in shares of Stericycle by 1,057.6% during the 2nd quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider’s stock worth $76,457,000 after acquiring an additional 1,201,653 shares in the last quarter. Alpine Associates Management Inc. acquired a new stake in shares of Stericycle in the 2nd quarter valued at about $62,298,000. Finally, Capital Research Global Investors boosted its position in shares of Stericycle by 13.4% in the 4th quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider’s stock valued at $296,762,000 after purchasing an additional 705,586 shares during the period. 98.82% of the stock is owned by institutional investors and hedge funds.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.